Pickard Colette, Thomas Rachel, Robertson Isabell, Macdonald Angus
Colette Pickard, Department of Surgery, Monklands District General Hospital, Airdrie, Lanarkshire, Scotland. Rachel Thomas, MD, FRCS, Department of Surgery, Monklands District General Hospital, Airdrie, Lanarkshire, Scotland. Isabell Robertson, BSc, RGN, Department of Surgery, Monklands District General Hospital, Airdrie, Lanarkshire, Scotland. Angus Macdonald, MD, FRCS, Honorary Clinical Associate Professor, University of Glasgow MVLS and Department of Surgery, Monklands District General Hospital, Airdrie, Lanarkshire, Scotland.
J Wound Ostomy Continence Nurs. 2018 May/Jun;45(3):239-241. doi: 10.1097/WON.0000000000000424.
The purpose of this study was to review our experience with palliative ostomy surgery in patients with bowel obstruction and advanced stage colorectal cancer.
A descriptive, retrospective review of data from a prospectively collected clinical database.
The sample comprised 86 patients (55 male) who underwent palliative surgery between October 1998 and January 2009.
All patients undergoing palliative stoma formation without resection for colorectal carcinoma were identified from a prospectively compiled colorectal cancer database. Patients having colorectal stent placement and bypass surgery were excluded from analysis.
The median age at surgery was 71 years (interquartile range, 65-79 years). The median survival following ostomy creation was 103 days (interquartile range, 19-263 days). Sixty-nine percent of participants (n = 59) survived 30 days and 18% (n=16) survived 12 months.
Our results confirm that patients undergoing palliative stoma formation have limited life expectancy. Nevertheless, these findings are encouraging when compared to the anticipated outcomes of untreated bowel obstruction.
本研究旨在回顾我们在肠梗阻及晚期结直肠癌患者中进行姑息性造口手术的经验。
对前瞻性收集的临床数据库中的数据进行描述性回顾性分析。
样本包括1998年10月至2009年1月期间接受姑息性手术的86例患者（55例男性）。
从前瞻性编制的结直肠癌数据库中识别出所有未行切除术而行姑息性造口术的患者。将接受结直肠支架置入和旁路手术的患者排除在分析之外。
手术时的中位年龄为71岁（四分位间距为65 - 79岁）。造口术后的中位生存期为103天（四分位间距为19 - 263天）。69%的参与者（n = 59）存活30天，18%（n = 16）存活12个月。
我们的结果证实，接受姑息性造口术的患者预期寿命有限。然而，与未经治疗的肠梗阻的预期结果相比，这些发现令人鼓舞。
